www.fdanews.com/articles/149257-roche-banks-on-new-drugs-as-herceptin-faces-hurdle
Roche Banks on New Drugs as Herceptin Faces Hurdle
September 6, 2012
Swiss drugmaker Roche Holding AG expects results from 19 late-stage clinical trials over the next 18 months, providing a stream of products to offset a potential near-term threat to breast cancer drug Herceptin, its third biggest seller.
Reuters
Reuters